MANE
NYSE ·

Veradermics Inc

Mid-Cap Stocks
$138.78
+0.29 (+0.21%)
MANE News1 articles
Veradermics Soars After Hair-Loss Drug Meets Trial Goals
Veradermics shares jumped 40% after its oral hair-loss drug VDPHL01 met all main goals in a Phase 2/3 trial, with patients seeing significant hair count increases.
Markets